comparemela.com
Home
Live Updates
Pembrolizumab Improves Disease-Free Survival for Muscle-Invasive Urothelial Carcinoma : comparemela.com
Pembrolizumab Improves Disease-Free Survival for Muscle-Invasive Urothelial Carcinoma
The late-breaking data at the 2024 American Society of Clinical Oncology Genitourinary Cancers Symposium included the results of KEYNOTE-123 for locally advanced resectable urothelial carcinoma.
Related Keywords
United States ,
American ,
,
National Cancer Institute ,
Pfizer ,
Merck Research Laboratories ,
National Institutes Of Health ,
Clinical Oncology Genitourinary Cancers ,
After Surgery ,
Localized Muscle Invasive Bladder Cancer ,
Locally Advanced Urothelial ,
National Cancer ,
Completion Date ,
Bladder Cancer Section ,
Genitourinary Malignancies Branch ,
National Institutes ,
comparemela.com © 2020. All Rights Reserved.